“…This may be partly explained by the specific binding of HuNoV to the oyster digestive tract through an A-like carbohydrate structure (which is indistinguishable from human blood group A antigen), other ligands such as sialic acids, and also through ionic bonding (Di Girolamo et al, 1977;Le Guyader et al, 2006;Tian et al, 2007). To avoid the marketing of virus-contaminated shellfish, end-product testing using molecular methods is one risk management option (ISO/TS 15216-1, 2017), however this approach is difficult, because in addition to HuNoV's, there may be a variety of other human enteric viruses present in the shellfish, such as hepatitis A virus, enterovirus, rotavirus or sapovirus ( Boxman et al, 2016;Kittigul et al, 2014;McLeod et al, 2009;Polo et al, 2015;Ueki et al, 2010) -testing for such a diversity of viruses presents both logistic and economic challenges. The plethora of viruses detected in shellfish is linked to the high diversity of viruses in human sewage, reflecting the microbiome of the local population, and thereby potentially favoring the dispersion of emerging viruses (Bisseux et al, 2018;Geoghegan et al,2016;Newton et al, 2015).…”